BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarkar S, Hobson AR, Hughes A, Growcott J, Woolf CJ, Thompson DG, Aziz Q. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology. 2003;124:18-25. [PMID: 12512025 DOI: 10.1053/gast.2003.50022] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Rittner HL, Brack A, Stein C. Pro-algesic versus analgesic actions of immune cells. Curr Opin Anaesthesiol 2003;16:527-33. [PMID: 17021507 DOI: 10.1097/00001503-200310000-00014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
2 Popp L, Häussler A, Olliges A, Nüsing R, Narumiya S, Geisslinger G, Tegeder I. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice. European Journal of Pain 2009;13:691-703. [DOI: 10.1016/j.ejpain.2008.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
3 Miki T, Matsunami M, Nakamura S, Okada H, Matsuya H, Kawabata A. ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis. Pain 2011;152:1373-81. [PMID: 21396778 DOI: 10.1016/j.pain.2011.02.019] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
4 Mokha JS, Hyams JS, Glidden NC, Balarezo F, Young E. Characterizing clinical features and location-specific gene expression profiles associated with pain burden in children with functional dyspepsia. Neurogastroenterol Motil 2021;:e14185. [PMID: 34120385 DOI: 10.1111/nmo.14185] [Reference Citation Analysis]
5 Bulmer DC, Botha CA, Wheeldon A, Grey K, Mein CA, Lee K, Knowles CH, Winchester WJ, Aziz Q. Evidence of a role for GTP cyclohydrolase-1 in visceral pain. Neurogastroenterol Motil 2015;27:656-62. [DOI: 10.1111/nmo.12538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Willert RP, Delaney C, Kelly K, Sharma A, Aziz Q, Hobson AR. Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification - evidence of central sensitization. Neurogastroenterol Motil. 2007;19:270-278. [PMID: 17391243 DOI: 10.1111/j.1365-2982.2006.00890.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
7 Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 2004;18:790-804. [PMID: 15117884 DOI: 10.1096/fj.03-0645rev] [Cited by in Crossref: 397] [Cited by in F6Publishing: 325] [Article Influence: 23.4] [Reference Citation Analysis]
8 Farmer AD, Ruffle JK, Aziz Q. The Role of Esophageal Hypersensitivity in Functional Esophageal Disorders. J Clin Gastroenterol 2017;51:91-9. [PMID: 28005634 DOI: 10.1097/MCG.0000000000000757] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 5.8] [Reference Citation Analysis]
9 Farmer AD, Aziz Q. Gut pain & visceral hypersensitivity. Br J Pain. 2013;7:39-47. [PMID: 26516496 DOI: 10.1177/2049463713479229] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
10 Kindt S, Tack J. Pathophysiology of noncardiac chest pain: not only acid. Dis Mon 2008;54:615-26. [PMID: 18725004 DOI: 10.1016/j.disamonth.2008.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kim SO, Duffy DM. Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal. Biol Reprod 2016;95:33. [PMID: 27307073 DOI: 10.1095/biolreprod.116.140574] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
12 Lin YM, Fu Y, Wu CC, Xu GY, Huang LY, Shi XZ. Colon distention induces persistent visceral hypersensitivity by mechanotranscription of pain mediators in colonic smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2015;308:G434-41. [PMID: 25540231 DOI: 10.1152/ajpgi.00328.2014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
13 Kondo T, Oshima T, Tomita T, Fukui H, Okada H, Watari J, Miwa H. The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers. Clin Gastroenterol Hepatol 2015;13:1249-1255.e1. [PMID: 25632805 DOI: 10.1016/j.cgh.2015.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Nakao K, Murase A, Ohshiro H, Okumura T, Taniguchi K, Murata Y, Masuda M, Kato T, Okumura Y, Takada J. CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 2007;322:686-94. [PMID: 17495127 DOI: 10.1124/jpet.107.122010] [Cited by in Crossref: 74] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
15 Sharma A, Paine P, Rhodes S, Warburton F, Chua YC, Aziz Q. The autonomic response to human esophageal acidification and the development of hyperalgesia: Autonomic profile and esophageal hyperalgesia. Neurogastroenterology & Motility 2012;24:e285-93. [DOI: 10.1111/j.1365-2982.2012.01929.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
16 Chen CL, Hsu PI. Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract. 2013;2013:653989. [PMID: 23935610 DOI: 10.1155/2013/653989] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
17 Rodríguez-Nogales A, Algieri F, Vezza T, Garrido-Mesa J, Molina-Tijeras JA, Rodríguez-Cabezas ME, Utrilla MP, Pischel I, Gálvez J. Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats. Nutrients 2019;11:E140. [PMID: 30634696 DOI: 10.3390/nu11010140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Willert RP, Woolf CJ, Hobson AR, Delaney C, Thompson DG, Aziz Q. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology. 2004;126:683-692. [PMID: 14988822 DOI: 10.1053/j.gastro.2003.11.047] [Cited by in Crossref: 144] [Cited by in F6Publishing: 124] [Article Influence: 8.5] [Reference Citation Analysis]
19 Buscher HC, Wilder-Smith OH, van Goor H. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain. 2006;10:363-370. [PMID: 16087373 DOI: 10.1016/j.ejpain.2005.06.006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 4.9] [Reference Citation Analysis]
20 Drewes AM, Gregersen H. Multimodal pain stimulation of the gastrointestinal tract. World J Gastroenterol 2006;12:2477-86. [PMID: 16688791 DOI: 10.3748/wjg.v12.i16.2477] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
21 Kondo T, Oshima T, Tomita T, Fukui H, Watari J, Okada H, Kikuchi S, Sasako M, Matsumoto T, Knowles CH, Miwa H. Prostaglandin E 2 mediates acid-induced heartburn in healthy volunteers. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013;304:G568-73. [DOI: 10.1152/ajpgi.00276.2012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
22 Joseph EK, Levine JD. Caspase signalling in neuropathic and inflammatory pain in the rat: Caspase signalling in pain. European Journal of Neuroscience 2004;20:2896-902. [DOI: 10.1111/j.1460-9568.2004.03750.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 133] [Article Influence: 8.5] [Reference Citation Analysis]
23 Kern M, Chai K, Lawal A, Shaker R. Effect of esophageal acid exposure on the cortical swallowing network in healthy human subjects. Am J Physiol Gastrointest Liver Physiol 2009;297:G152-8. [PMID: 19407219 DOI: 10.1152/ajpgi.00062.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
24 Farmer AD, Aziz Q. Recent advances in chronic visceral pain. Current Opinion in Supportive & Palliative Care 2008;2:116-21. [DOI: 10.1097/spc.0b013e328300548a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Bley KR, Bhattacharya A, Daniels DV, Gever J, Jahangir A, O'Yang C, Smith S, Srinivasan D, Ford AP, Jett MF. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists. Br J Pharmacol 2006;147:335-45. [PMID: 16331286 DOI: 10.1038/sj.bjp.0706554] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
26 Jackson M, Simpson KH. Spinal cord stimulation in a patient with persistent oesophageal pain. Pain 2004;112:406-8. [DOI: 10.1016/j.pain.2004.09.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
27 Farmer AD, Aziz Q. Mechanisms of visceral pain in health and functional gastrointestinal disorders. Scand J Pain 2014;5:51-60. [PMID: 29913680 DOI: 10.1016/j.sjpain.2014.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
28 Shahin AY, Osman AM. Parietal peritoneal closure and persistent postcesarean pain. International Journal of Gynecology & Obstetrics 2009;104:135-9. [DOI: 10.1016/j.ijgo.2008.09.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
29 Akbar A, Walters JR, Ghosh S. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Aliment Pharmacol Ther. 2009;30:423-435. [PMID: 19493256 DOI: 10.1111/j.1365-2036.2009.04056.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
30 Arendt-nielsen L, Hoeck HC. Optimizing the early phase development of new analgesics by human pain biomarkers. Expert Review of Neurotherapeutics 2014;11:1631-51. [DOI: 10.1586/ern.11.147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
31 Woolf CJ. Pain amplification-A perspective on the how, why, when, and where of central sensitization. J Appl Behav Res 2018;23:e12124. [DOI: 10.1111/jabr.12124] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
32 Kuiken SD, Tytgat GN, Boeckxstaens GE. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence. Aliment Pharmacol Ther. 2005;21:633-651. [PMID: 15771750 DOI: 10.1111/j.1365-2036.2005.02392.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
33 Chua YC, Ng KS, Sharma A, Jafari J, Surguy S, Yazaki E, Knowles CH, Aziz Q. Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers - a placebo-controlled study: Randomised clinical trial: pregabalin attenuates oesophageal hypersensitivity. Alimentary Pharmacology & Therapeutics 2012;35:319-26. [DOI: 10.1111/j.1365-2036.2011.04955.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
34 Hobson AR, Aziz Q. Brain imaging and functional gastrointestinal disorders: has it helped our understanding? Gut. 2004;53:1198-1206. [PMID: 15247191 DOI: 10.1136/gut.2003.035642] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
35 Spiller RC. Potential future therapies for Irritable Bowel Syndrome: Will Disease Modifying Therapy as Opposed to Symptomatic Control Become a Reality? Gastroenterology Clinics of North America 2005;34:337-54. [DOI: 10.1016/j.gtc.2005.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Knowles CH, Aziz Q. Basic and clinical aspects of gastrointestinal pain. Pain. 2009;141:191-209. [PMID: 19155134 DOI: 10.1016/j.pain.2008.12.011] [Cited by in Crossref: 111] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
37 Armstrong D, Sifrim D. New pharmacologic approaches in gastroesophageal reflux disease. Gastroenterol Clin North Am. 2010;39:393-418. [PMID: 20951909 DOI: 10.1016/j.gtc.2010.08.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
38 Hall A, Billinton A, Brown SH, Chowdhury A, Clayton NM, Giblin GM, Gibson M, Goldsmith PA, Hurst DN, Naylor A, Peet CF, Scoccitti T, Wilson AW, Winchester W. Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP1 receptor antagonist for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters 2009;19:2599-603. [DOI: 10.1016/j.bmcl.2009.02.112] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Olesen AE, Andresen T, Staahl C, Drewes AM. Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev. 2012;64:722-779. [PMID: 22722894 DOI: 10.1124/pr.111.005447] [Cited by in Crossref: 141] [Cited by in F6Publishing: 104] [Article Influence: 15.7] [Reference Citation Analysis]
40 Kondo T, Sei H, Yamasaki T, Tomita T, Ohda Y, Oshima T, Fukui H, Watari J, Miwa H. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol 2017;52:1081-9. [DOI: 10.1007/s00535-017-1308-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
41 Anand P, Aziz Q, Willert R, van Oudenhove L. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil. 2007;19:29-46. [PMID: 17280584 DOI: 10.1111/j.1365-2982.2006.00873.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 108] [Article Influence: 9.5] [Reference Citation Analysis]
42 Holzer P. Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets. Expert Opin Ther Targets. 2004;8:107-123. [PMID: 15102553 DOI: 10.1517/14728222.8.2.107] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
43 Arendt-Nielsen L, Nielsen TA, Gazerani P. Translational pain biomarkers in the early development of new neurotherapeutics for pain management. Expert Rev Neurother 2014;14:241-54. [PMID: 24490970 DOI: 10.1586/14737175.2014.884925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
44 Zhou YM, Wu L, Wei S, Jin Y, Liu TT, Qiu CY, Hu WP. Enhancement of acid-sensing ion channel activity by prostaglandin E2 in rat dorsal root ganglion neurons. Brain Res 2019;1724:146442. [PMID: 31513790 DOI: 10.1016/j.brainres.2019.146442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
45 Woodland P, Amarasinghe G, Sifrim D. Emerging therapeutic options in GERD. Best Practice & Research Clinical Gastroenterology 2013;27:455-67. [DOI: 10.1016/j.bpg.2013.06.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Murai N, Tsukamoto M, Tamura S, Aoki T, Matsuoka N. Antinociceptive effects of AS1069562, the (+)-isomer of indeloxazine, on spinal hypersensitivity induced by intrathecal injection of prostaglandin in mice: Comparison with duloxetine and amitriptyline. European Journal of Pharmacology 2014;733:54-61. [DOI: 10.1016/j.ejphar.2014.03.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
47 Hobson AR, Furlong PL, Sarkar S, Matthews PJ, Willert RP, Worthen SF, Unsworth BJ, Aziz Q. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology. 2006;130:80-88. [PMID: 16401471 DOI: 10.1053/j.gastro.2005.10.016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
48 Umei K, Nishigaya Y, Kondo A, Tatani K, Tanaka N, Kohno Y, Seto S. Novel pyrazolo[1,5- a ]pyridines as orally active EP 1 receptor antagonists: Synthesis, structure-activity relationship studies, and biological evaluation. Bioorganic & Medicinal Chemistry 2017;25:2635-42. [DOI: 10.1016/j.bmc.2017.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
49 Sarkar S, Woolf CJ, Hobson AR, Thompson DG, Aziz Q. Perceptual wind-up in the human oesophagus is enhanced by central sensitisation. Gut 2006;55:920-5. [PMID: 16492716 DOI: 10.1136/gut.2005.073643] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
50 Durrenberger PF, Facer P, Casula MA, Yiangou Y, Gray RA, Chessell IP, Day NC, Collins SD, Bingham S, Wilson AW, Elliot D, Birch R, Anand P. Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study. BMC Neurol 2006;6:1. [PMID: 16393343 DOI: 10.1186/1471-2377-6-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
51 Su X, Leon LA, Wu CW, Morrow DM, Jaworski J, Hieble JP, Lashinger ESR, Jin J, Edwards RM, Laping NJ. Modulation of bladder function by prostaglandin EP 3 receptors in the central nervous system. American Journal of Physiology-Renal Physiology 2008;295:F984-94. [DOI: 10.1152/ajprenal.90373.2008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
52 Emerenziani S, Ribolsi M, Guarino MPL, Balestrieri P, Altomare A, Rescio MP, Cicala M. Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients. Neurogastroenterol Motil 2014;26:108-14. [DOI: 10.1111/nmo.12239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
53 Liu C, Jiang W, Muller MH, Grundy D, Kreis ME. Sensitization of mesenteric afferents to chemical and mechanical stimuli following systemic bacterial lipopolysaccharide. Neurogastroenterol Motil 2005;17:89-101. [DOI: 10.1111/j.1365-2982.2004.00585.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
54 Drewes AM, Reddy H, Staahl C, Pedersen J, Funch-Jensen P, Arendt-Nielsen L, Gregersen H. Sensory-motor responses to mechanical stimulation of the esophagus after sensitization with acid. World J Gastroenterol. 2005;4367-4374. [DOI: 10.3748/wjg.v11.i28.4367] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
55 Rukwied R, Chizh BA, Lorenz U, Obreja O, Margarit S, Schley M, Schmelz M. Potentiation of nociceptive responses to low pH injections in humans by prostaglandin E2. J Pain 2007;8:443-51. [PMID: 17337250 DOI: 10.1016/j.jpain.2006.12.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
56 Heatley M, Rose K, Weston C. The heart and the oesophagus: intimate relations. Postgrad Med J 2005;81:515-8. [PMID: 16085743 DOI: 10.1136/pgmj.2004.029074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
57 Woodward DF, Jones RL, Narumiya S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 2011;63:471-538. [PMID: 21752876 DOI: 10.1124/pr.110.003517] [Cited by in Crossref: 290] [Cited by in F6Publishing: 232] [Article Influence: 29.0] [Reference Citation Analysis]
58 Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil. 2010;16:8-21. [PMID: 20535321 DOI: 10.5056/jnm.2010.16.1.8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 7.7] [Reference Citation Analysis]
59 Willert RP, Delaney C, Hobson AR, Thompson DG, Woolf CJ, Aziz Q. Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity. European Journal of Pain 2006;10:487-487. [DOI: 10.1016/j.ejpain.2005.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
60 Ducharme Y, Blouin M, Carrière M, Chateauneuf A, Côté B, Denis D, Frenette R, Greig G, Kargman S, Lamontagne S, Martins E, Nantel F, O’neill G, Sawyer N, Metters KM, Friesen RW. 2,3-Diarylthiophenes as selective EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2005;15:1155-60. [DOI: 10.1016/j.bmcl.2004.12.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
61 Mckeown SC, Hall A, Giblin GM, Lorthioir O, Blunt R, Lewell XQ, Wilson RJ, Brown SH, Chowdhury A, Coleman T, Watson SP, Chessell IP, Pipe A, Clayton N, Goldsmith P. Identification of novel pyrazole acid antagonists for the EP1 receptor. Bioorganic & Medicinal Chemistry Letters 2006;16:4767-71. [DOI: 10.1016/j.bmcl.2006.06.086] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
62 Arendt-nielsen L, Yarnitsky D. Experimental and Clinical Applications of Quantitative Sensory Testing Applied to Skin, Muscles and Viscera. The Journal of Pain 2009;10:556-72. [DOI: 10.1016/j.jpain.2009.02.002] [Cited by in Crossref: 273] [Cited by in F6Publishing: 226] [Article Influence: 22.8] [Reference Citation Analysis]
63 Jones RL, Giembycz MA, Woodward DF. Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol 2009;158:104-45. [PMID: 19624532 DOI: 10.1111/j.1476-5381.2009.00317.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 95] [Article Influence: 10.0] [Reference Citation Analysis]
64 Qin C, Farber JP, Foreman RD. Intraesophageal chemicals enhance responsiveness of upper thoracic spinal neurons to mechanical stimulation of esophagus in rats. Am J Physiol Gastrointest Liver Physiol 2008;294:G708-16. [PMID: 18187515 DOI: 10.1152/ajpgi.00477.2007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
65 Paine PA, Hamdy S, Chitnis X, Gregory LJ, Giampietro V, Brammer M, Williams S, Aziz Q. Modulation of activity in swallowing motor cortex following esophageal acidification: a functional magnetic resonance imaging study. Dysphagia 2008;23:146-54. [PMID: 17955290 DOI: 10.1007/s00455-007-9114-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
66 Staahl C, Drewes AM. Experimental Human Pain Models: A Review of Standardised Methods for Preclinical Testing of Analgesics. Pharmacol Toxicol 2004;95:97-111. [DOI: 10.1111/j.1742-7843.2004.950301.x] [Cited by in Crossref: 107] [Cited by in F6Publishing: 90] [Article Influence: 6.3] [Reference Citation Analysis]
67 Wada N, Ameda K, Furuno T, Okada H, Date I, Kakizaki H. Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis. J Urol 2015;193:1987-93. [PMID: 25595860 DOI: 10.1016/j.juro.2015.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
68 Luscombe KS, McDonnell NJ, Muchatuta NA, Paech MJ, Nathan EA. A randomised comparison of parecoxib versus placebo for pain management following minor day stay gynaecological surgery. Anaesth Intensive Care 2010;38:141-8. [PMID: 20191790 DOI: 10.1177/0310057X1003800123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
69 Mckeown SC, Hall A, Blunt R, Brown SH, Chessell IP, Chowdhury A, Giblin GM, Healy MP, Johnson MR, Lorthioir O, Michel AD, Naylor A, Lewell X, Roman S, Watson SP, Winchester WJ, Wilson RJ. Identification of novel glycine sulfonamide antagonists for the EP1 receptor. Bioorganic & Medicinal Chemistry Letters 2007;17:1750-4. [DOI: 10.1016/j.bmcl.2006.12.060] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
70 Bingham S, Beswick PJ, Blum DE, Gray NM, Chessell IP. The role of the cylooxygenase pathway in nociception and pain. Seminars in Cell & Developmental Biology 2006;17:544-54. [DOI: 10.1016/j.semcdb.2006.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
71 Shahin AY, Osman AM. Intraperitoneal Lidocaine Instillation and Postcesarean Pain After Parietal Peritoneal Closure: A Randomized Double Blind Placebo-controlled Trial. The Clinical Journal of Pain 2010;26:121-7. [DOI: 10.1097/ajp.0b013e3181b99ddd] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
72 Bredenoord AJ. Mechanisms of Reflux Perception in Gastroesophageal Reflux Disease: A Review. American Journal of Gastroenterology 2012;107:8-15. [DOI: 10.1038/ajg.2011.286] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
73 Hobson AR, Furlong PL, Aziz Q. Oesophageal afferent pathway sensitivity in non-erosive reflux disease. Neurogastroenterol Motil 2008;20:877-83. [PMID: 18410265 DOI: 10.1111/j.1365-2982.2008.01122.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
74 Page AJ, Blackshaw LA. Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. Handb Exp Pharmacol 2009;:227-57. [PMID: 19655109 DOI: 10.1007/978-3-540-79090-7_7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
75 Willert RP, Hobson AR, Delaney C, Hicks KJ, Dewit OE, Aziz Q. Neurokinin-1 receptor antagonism in a human model of visceral hypersensitivity: SUBSTANCE P AND VISCERAL HYPERSENSITIVITY. Alimentary Pharmacology & Therapeutics 2007;25:309-16. [DOI: 10.1111/j.1365-2036.2006.03190.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
76 Holzer P, Wultsch T, Edelsbrunner M, Mitrovic M, Shahbazian A, Painsipp E, Bock E, Pabst MA. Increase in gastric acid-induced afferent input to the brainstem in mice with gastritis. Neuroscience 2007;145:1108-19. [PMID: 17303342 DOI: 10.1016/j.neuroscience.2006.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
77 Drewes AM, Pedersen J, Reddy H, Rasmussen K, Funch-Jensen P, Arendt-Nielsen L, Gregersen H. Central sensitization in patients with non-cardiac chest pain: a clinical experimental study. Scand J Gastroenterol. 2006;41:640-649. [PMID: 16754535 DOI: 10.1080/00365520500442559] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
78 Hall A, Bit RA, Brown SH, Chaignot HM, Chessell IP, Coleman T, Giblin GM, Hurst DN, Kilford IR, Lewell XQ, Michel AD, Mohamed S, Naylor A, Novelli R, Skinner L, Spalding DJ, Tang SP, Wilson RJ. Discovery of novel biaryl heterocyclic EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2006;16:2666-71. [DOI: 10.1016/j.bmcl.2006.02.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
79 Matthews PJ, Knowles CH, Chua YC, Delaney C, Hobson AR, Aziz Q. Effects of the concentration and frequency of acid infusion on the development and maintenance of esophageal hyperalgesia in a human volunteer model. Am J Physiol Gastrointest Liver Physiol 2008;294:G914-7. [PMID: 18258794 DOI: 10.1152/ajpgi.00445.2007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
80 Weijenborg PW, Bredenoord AJ. How reflux causes symptoms: Reflux perception in gastroesophageal reflux disease. Best Practice & Research Clinical Gastroenterology 2013;27:353-64. [DOI: 10.1016/j.bpg.2013.06.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]